PerkinElmer acquires Covaris

Hands Shaking Deal Social

PerkinElmer has signed an agreement to acquire life sciences firm Covaris, which will expand its life sciences portfolio and provide entrance into the high-growth diagnostics end market.

Both companies are majority owned by New Mountain Capital, a New York-based investment firm; financial and other terms of the transaction were not disclosed.

New Mountain Capital acquired the applied, food, and enterprise services businesses of PerkinElmer in March; its former life sciences and diagnostics divisions rebranded as Revvity.  

PerkinElmer is a global analytical services and solutions provider serving the biopharma, food, environmental, safety and applied end markets, with a portfolio that includes atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables, and reagents.

Woburn, MA-based Covaris develops instruments, consumables, and reagents for high-throughput genomic and proteomic analysis.

Page 1 of 12
Next Page